Recent studies suggest that altered expression of TGF-β receptors contributes to ESCC progression, and elevated expression of inhibitory proteins of TGF-β signaling correlates with poor prognosis of ESCC [28, 29]. This evidence concerns the gene TGFB1 and esophageal squamous cell carcinoma.